| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 29 May 2025 | 19 May 2025 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve Pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 the Meeting of the Board of Directors of the Company is scheduled to be held on Thursday May 29 2025 at Registered office of the Company inter alia to consider approve and take on record the Audited Financial Results (both standalone and consolidated) for the 4th quarter of FY 2024-25 and for the Financial year 2024-25 ended on March 31 2025. Board at their meeting held on 29.05.2025 interalia approved audited standalone and consolidated financial results for the quarter/year ended 31.03.2025. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, inter-alia the outcome of the Meeting of the Board of Directors of the Company held on Thursday, May 29, 2025, at 04:20 p.m. and concluded at 6.55 p.m. 1. Approved Audited Financial Results (standalone and consolidated) for the quarter/year ended March 31, 2025. 2. Noted Auditors Report on Annual Audited Financial Statement (both standalone & Consolidated) for the financial year ended March 31, 2025 alongwith declaration from the CFO that Auditors report contain unmodified opinion on financial Results. 3. approved the appointment of M/s. ATCS & Associates, Company Secretaries (Unique Identification No: P2017RJ063900 and Peer Review Certificate No. 3381/2023) as Secretarial Auditor of the Company (As per BSE Announcement Dated on 29/05/2025) | ||
| Board Meeting | 13 Feb 2025 | 4 Feb 2025 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 inter alia to consider and approve Intimation of the Board Meeting scheduled to be held on 13.02.2025 pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 inter alia to consider approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 3rd quarter/nine months ended on December 31 2024 of the Financial Year 2024-25. The Board at its Meeting held on February 13, 2025 approved interalia the Unaudited Financial Results (Standalone and consolidated) for 3rd quarter/ nine months ended December 31, 2024 (As Per BSE Announcement Dated on 13.02.2025) | ||
| Board Meeting | 13 Nov 2024 | 31 Oct 2024 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve The 261st Meeting of the Board of Directors of the Company, is scheduled to be held on Wednesday, November 13, 2024 through video conferencing/Audio visual connection, inter alia, to consider, approve and take on record the Un-audited Financial Results (both standalone and consolidated) for the 2nd quarter/1st half year ended on September 30, 2024 of the Financial Year 2024-25. Board approved the Un-Audited Financial Results (Standalone and Consolidated) for the 2nd quarter/1st half year of FY 2024-25 ended on September 30, 2024 of the Company. Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we are pleased to inform, that the Board of Directors of the Company at their Board Meeting held on Wednesday, November 13, 2024 interalia approved Un-Audited Financial Results (standalone and consolidated) for the 2nd quarter/ 1st half year ended September 30, 2024 of the FY 2024-25. Copy of the approved Un-Audited Financial Results (standalone and consolidated) for the 2nd quarter/ 1st half year ended September 30, 2024 of the FY 2024-25 alongwith the Limited Review report thereon are enclosed herewith. The Board meeting was started at 4:40 p.m. and concluded at 6:45 p.m (As per BSE Announcement Dated on 13/11/2024) | ||
| Board Meeting | 13 Aug 2024 | 2 Aug 2024 |
| Sunil Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve Inter-alia to consider approve and take on record the Un-Audited Financial Results (both standalone and consolidated) for the 01st quarter ended on June 30 2024 of the financial year 2024-25. The Board approved interalia Un-audited Financial results (both standalone and consolidated) for the 1st quarter of Financial year 2024-25 ended on June 30, 2024 at the Board Meeting held on August 13, 2024. (As Per BSE Announcement Dated on: 13/08/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.